These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19336826)

  • 1. Supreme Court rules Wyeth's Phenergan warnings were inadequate.
    Lavine G
    Am J Health Syst Pharm; 2009 Apr; 66(8):698, 700. PubMed ID: 19336826
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in health law. Wyeth v. Levine: challenging implied pre-emption for drugs.
    Nair P
    J Law Med Ethics; 2009; 37(3):527-30. PubMed ID: 19791315
    [No Abstract]   [Full Text] [Related]  

  • 3. Warning signs.
    Nature; 2008 Mar; 452(7185):254. PubMed ID: 18354433
    [No Abstract]   [Full Text] [Related]  

  • 4. Wyeth v Levine: implications for public health policy and practice.
    David S; Rosenbaum S
    Public Health Rep; 2010; 125(3):494-7. PubMed ID: 20433045
    [No Abstract]   [Full Text] [Related]  

  • 5. Good law from tragic facts--Congress, the FDA, and preemption.
    Annas GJ
    N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383
    [No Abstract]   [Full Text] [Related]  

  • 6. The Supreme Court, preemption, and malpractice liability.
    Kesselheim AS; Studdert DM
    N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672
    [No Abstract]   [Full Text] [Related]  

  • 7. Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels.
    Boumil MM; Curfman G
    JAMA; 2018 Aug; 320(6):547-548. PubMed ID: 30039167
    [No Abstract]   [Full Text] [Related]  

  • 8. Impossible? Outlawing state safety laws for generic drugs.
    Glantz LH; Annas GJ
    N Engl J Med; 2011 Aug; 365(8):681-3. PubMed ID: 21830958
    [No Abstract]   [Full Text] [Related]  

  • 9. PLIVA v. Mensing: generic consumers' unfortunate hand.
    Lee SB
    Yale J Health Policy Law Ethics; 2012; 12(2):209-63. PubMed ID: 23175916
    [No Abstract]   [Full Text] [Related]  

  • 10. The Supreme Court's Latest Ruling on Drug Liability and its Implications for Future Failure-to-Warn Litigation.
    Morten CJ; Kesselheim AS; Ross JS
    J Law Med Ethics; 2019 Dec; 47(4):783-787. PubMed ID: 31957583
    [No Abstract]   [Full Text] [Related]  

  • 11. Science and the Supreme Court: Cases to watch in 2018.
    Reardon S
    Nature; 2018 Oct; 562(7726):175. PubMed ID: 30301986
    [No Abstract]   [Full Text] [Related]  

  • 12. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.
    Kesselheim AS
    Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk, responsibility, and generic drugs.
    Kesselheim AS; Avorn J; Greene JA
    N Engl J Med; 2012 Nov; 367(18):1679-81. PubMed ID: 23113477
    [No Abstract]   [Full Text] [Related]  

  • 14. Off-label drug use and promotion: balancing public health goals and commercial speech.
    Kesselheim AS
    Am J Law Med; 2011; 37(2-3):225-57. PubMed ID: 21847880
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 16. Two masters.
    Schneider CE
    Hastings Cent Rep; 2010; 40(1):9-10. PubMed ID: 20166509
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of Wyeth v. Levine on FDA regulation of prescription drugs.
    Ausness RC
    Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wyeth preemption case ruling sparks labeling confusion.
    Allison M
    Nat Biotechnol; 2009 May; 27(5):399-400. PubMed ID: 19430423
    [No Abstract]   [Full Text] [Related]  

  • 19. Supreme Court rules in favor of 'pay-for-delay' settlements.
    Sklan A
    Pharm Pat Anal; 2013 Sep; 2(5):582-3. PubMed ID: 24386654
    [No Abstract]   [Full Text] [Related]  

  • 20. How the FDA can overturn Wyeth v. Levine.
    Gostanian A
    Am J Law Med; 2010; 36(1):248-68. PubMed ID: 20481407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.